During development, mesodermal progenitors from the first heart field (FHF) form a primitive cardiac tube, to which progenitors from the second heart field (SHF) are added. The contribution of FHF and SHF progenitors to the adult zebrafish heart has not been studied to date. Here we find, using genetic tbx5a lineage tracing tools, that the ventricular myocardium in the adult zebrafish is mainly derived from tbx5a+ cells, with a small contribution from tbx5a− SHF progenitors. Notably, ablation of ventricular tbx5a+-derived cardiomyocytes in the embryo is compensated by expansion of SHF-derived cells. In the adult, tbx5a expression is restricted to the trabeculae and excluded from the outer cortical layer. tbx5a-lineage tracing revealed that trabecular cardiomyocytes can switch their fate and differentiate into cortical myocardium during adult heart regeneration. We conclude that a high degree of cardiomyocyte cell fate plasticity contributes to efficient regeneration.
The zebrafish is an established model organism to study heart regeneration, in which pre-existing cardiomyocytes proliferate to replace the lost myocardium1,2,3. The zebrafish myocardium is formed by an inner trabecular layer, a thin primordial layer, and an outer cortical layer. During embryonic development, cells from the primordial layer give rise to trabeculae4. Later, in the juvenile, trabecular cardiomyocytes breach the primordial layer and form the cortical myocardium5,6. Previous clonal analysis suggested that during adult heart regeneration, the cortical myocardium is rebuilt by cardiomyocytes from the same layer5, suggesting some degree of commitment to a particular myocardial layer. A higher degree of plasticity had been observed in the embryonic heart, whereby atrial cardiomyocytes were reported to be able to regenerate the cardiac ventricle7.
The vertebrate heart is formed from mesodermal precursor cells derived from the first and second heart fields, also called FHF and SHF, respectively. Cells from the FHF form the embryonic heart tube to which cells from the SHF are added to allow further growth. FHF and SHF progenitors have also been described in the zebrafish8,9,10,11,12. Regulatory elements from the draculin (drl) gene have been used to label a population of lateral plate mesoderm progenitors that give rise to cardiomyocytes of the primitive heart tube, providing a genetic marker to trace FHF-derived myocardium11. Latent tgf beta binding protein 3 (ltbp3) expression marks a distal drl-negative domain and has been proposed as a SHF marker12. Of note, neither drl nor ltbp3 are established FHF and SHF markers in other vertebrates including mammals11.
In the mouse, retrospective clonal analysis revealed that FHF-derived cells predominantly give rise to the left ventricle, whereas the SHF yields the right ventricle and large parts of the atria13,14. Further studies on the contribution of cardiac precursor cells to the mammalian heart come from genetic lineage tracing approaches, which are based on following the fate of cells that expressed a particular gene at a given time point of embryonic development15,16,17. A key gene used to trace the fate of cardiac precursor cells is Tbx5, encoding a T-box transcription factor, which serves as an early cardiac marker expressed in the developing heart tube18,19. Genetic lineage tracing analysis of Tbx5-expressing cells has revealed a strong contribution to the left ventricular myocardium, recapitulating the fate of FHF progenitors in this cardiac chamber20.
Zebrafish have two Tbx5-encoding genes, tbx5a and tbx5b; tbx5a expression levels during heart development are higher than those of tbx5b, and tbx5a mutants recapitulate key phenotypes of mammalian Tbx5 perturbations21,22,23. We thus decided to generate genetic tools to study the contribution of the FHF to the adult ventricle during homeostasis and regeneration in the zebrafish using regulatory sequences of tbx5a. We describe that in zebrafish the early heart tube is formed by tbx5a-derived cardiomyocytes to which SHF-derived tbx5a- cardiomyocytes are added. Even though their contribution to the adult heart is minimal, SHF-derived cells can give rise to a fully functional ventricle if tbx5a-derived cells are genetically ablated. In the adult heart, tbx5a expression is persistent only in the trabecular myocardium, allowing to distinguish this layer from the cortical myocardium. Genetic fate mapping of trabecular tbx5a+ cells shows that these cells contribute to regenerate the outer cortical layer. Together, our findings show a high degree of cardiomyocyte fate plasticity during zebrafish heart regeneration, during both embryonic stages and in the adult.
Contribution of tbx5a+ cardiomyocytes to the adult ventricle
We used the fluorescent bacterial artificial chromosome (BAC) transgenic reporter line tbx5a:GFP, driving green fluorescent protein (GFP) expression under the control of the tbx5a cis-regulatory elements24. The overall GFP expression pattern of tbx5a:GFP recapitulated that of endogenous tbx5a expression in embryos (Supplementary Fig. 1a, b; n = 7/7). We analysed the expression of tbx5a:GFP in the early heart tube, before the addition of SHF progenitors. At this stage, the heart tube is formed by a single sheet of cardiomyocytes named the primordial layer5. Homogeneous tbx5a:GFP expression was detected in the whole embryonic myocardium at 32 hours postfertilisation (hpf) (Fig. 1a–c; n = 5/5). After this stage, at 56 hpf, (Fig. 1d–f; n = 3/3), a GFP− region of myocardium started to become visible in the cranial portion of the heart tube, which remained reporter-negative at 72 hpf (Fig. 1g–i; Supplementary Movie 1, n = 5/5), 4 days postfertilisation (dpf) (Fig. 1j–l; n = 9/9), and at 5 dpf (Fig. 1m–o; n = 6/6), concomitant with the reported addition of SHF progenitors to the ventricular myocardium during these stages8,12. The GFP expression pattern was confirmed by gfp messenger RNA in situ hybridisation on heart sections of embryos at 2–5 dpf (Supplementary Fig. 1c–g). Comparison of the expression domains at 56 and 72 hpf between tbx5a:GFP and the previously reported FHF marker drl:mCherry revealed an overlap of both domains in the proximal part of the ventricle close to the atrioventricular canal (AVC) and in the outer curvature of the ventricle (Supplementary Fig. 2a–h and Supplementary Movies 2 and 3; 56 hpf, n = 5/5; 72 hpf, n = 7/7). Of note, the expression domain of tbx5a:GFP was more extensive toward the distal myocardium. This might indicate that drl expression is downregulated faster in FHF-derived cells than tbx5a, or that part of the proximal SHF-derived myocardium expresses tbx5a. Nonetheless, a clear tbx5a:GFP/drl:mCherry double-negative domain was present in the inner curvature and distal-most portion of the larval ventricle (Supplementary Fig. 2a–h and Supplementary Movies 2 and 3). This tbx5a:GFP− region was further expressing transiently injected ltbp3:TagRFP-2A-Cre12, indicating SHF-derived ventricular myocardium (Supplementary Fig. 2i–l and Supplementary Movie 4). Thus, in the embryonic heart, tbx5a expression marks cardiomyocytes in the primitive heart tube and is absent from a population of distally located ventricular cardiomyocytes, which from their expression pattern and temporal appearance match with previous descriptions of the most distal SHF-derived cells12.
We next sought to chart tbx5a expression in the adult zebrafish heart. During zebrafish heart maturation, a third myocardial layer forms enveloping the primordial layer, named cortical layer. Clonal analysis suggested that these myocardial layer derives from trabecular cardiomyocytes5. We still detected high levels of endogenous tbx5a mRNA and tbx5a:GFP expression in the adult zebrafish ventricle (Fig. 2a, b and Supplementary Fig. 3; n = 8/8). tbx5a:GFP expression was restricted to the trabecular myocardium and absent from the cortical layer (Fig. 2c, d), coinciding with the recently reported pattern obtained using an enhancer fragment located 16 kb upstream of the tbx5a transcription start site25. Expression spread through most of the trabecular myocardium, with a gradient from the apex (high expression) to the basal part close to the bulbus arteriosus (BA) (lower expression levels). In addition, we observed a region in the basal ventricle, close to the atrium, in which we detected GFP− trabecular cardiomyocytes. No GFP expression can be detected in these cells beyond background and we therefore refer to this myocardial territory as basal tbx5a− region (Fig. 2e, f; n = 13/13; Supplementary Fig. 4).
tbx5a− cardiomyocytes in the adult heart could derive from embryonic tbx5a+ cells that switched off their expression or from progenitor cells that never expressed tbx5a. To test these possibilities, we generated transgenic lines for inducible genetic fate mapping of tbx5a-expressing cells (Fig. 3a). In double-transgenic tbx5a:mCherry-p2A-CreERT2;ubb:loxP-lacZ-STOP-loxP-GFP26 embryos, mCherry labels tbx5a-expressing cells and GFP labels the progeny of tbx5a+ cells that expressed CreERT2 recombinase at the time of 4-Hydroxytamoxifen (4-OHT)-induced recombination. This transgenic combination was not leaky and GFP-expressing cells were visible only upon 4-OHT administration (Fig. 3b; n = 5/5). When recombined during embryogenesis, GFP+ cells were found in the atrium and ventricle of the larval heart but never in the distal portion of the ventricular myocardium (Fig. 3c–f; 8/8; Supplementary Fig. 5 and Supplementary Movie 5, n = 9/9). Few epicardial cells were also tbx5a-derived, consistent with tbx5a:tdTomato expression observed in a subset of embryonic epicardial cells (Supplementary Fig. 6; n = 6/7). When analysed in adult hearts, the cortical layer was mCherry−, in agreement with our observations using the reporter tbx5a:GFP. Nonetheless, most of the cortical layer was GFP+ and thus derived from a tbx5a+ embryonic cell population that switched off tbx5a expression (Fig. 3g–n; n = 5/5; Supplementary Fig. 7, 8).
Akin to the GFP pattern observed in tbx5a:GFP adult hearts, a basal domain of the ventricle close to the BA was also mCherry− (Fig. 3g–j and 3o–r, and Supplementary Fig. 7, 8; n = 5/5). Furthermore, this domain was also GFP−, suggesting that it derives from the tbx5a− distal embryonic ventricle. Thus, we propose that tbx5a+-derived cells in the adult heart predominantly comprise the FHF derivatives of the embryonic heart and the tbx5a− domain in the basal ventricle close to the atrium and BA is SHF-derived. Taken together, our genetic lineage tracing of embryonic myocardial populations into adulthood in zebrafish reveal a fate compartmentalisation of tbx5a− and tbx5a+-derived cardiomyocytes starting in embryogenesis that results in distinguishable ventricle domains in the absence of septation.
SHF progenitors compensate ablated tbx5a+ cardiomyocytes
Previous results have indicated that atrial cardiomyocytes acquire a ventricular phenotype upon injury in the embryonic heart7. To explore whether SHF progenitors can compensate for a loss of FHF-derived cells, we generated vmhcl:loxP-tagBFP-loxP-mCherry-NTR, a transgenic line to specifically mark and ablate ventricular cardiomyocytes using the ventricular myosin heavy chain like (vmhcl) cis-regulatory elements (Fig. 4a; Supplementary Fig. 9; n = 10/10). vmhcl is expressed exclusively in ventricular and not atrial cardiomyocytes27. We crossed vmhcl:loxP-tagBFP-loxP-mCherry-NTR with tbx5a:CreERT2. This allowed to lineage-trace tbx5a+ (mCherry+) and tbx5a− ventricular cardiomyocytes (tagBFP+). Furthermore, this genetic strategy allows the ablation of tbx5a+ ventricular cardiomyocytes by adding Metronidazole (Mtz) to induce cell death in nitroreductase (NTR)-expressing cells28. Administration of 4-OHT from 24 to 48 hpf induced the expression of mCherry-NTR in tbx5a-derived cardiomyocytes in the trabecular and primordial layer of the embryonic ventricle, with the exception of the distal-most part at the cranial pole (Fig. 4b, c, n = 7/7). In adult hearts, most ventricular cardiomyocytes were mCherry+. Only a small portion of cardiomyocytes close to the BA and AVC was tagBFP+ (Fig. 4d, e), coinciding with the results obtained doing lineage tracing using tbx5a:mCherry-p2A-CreERT2;ubb:loxP-lacZ-STOP-loxP-GFP. To specifically ablate mCherry+ cardiomyocytes we administered Mtz from 4 to 7 dpf (Supplementary Fig. 10). Surprisingly, 30 days later, a complete ventricle had regenerated from tagBFP+ cardiomyocytes, suggesting that SHF-derived ventricular cardiomyocytes are able to compensate the genetic ablation of the FHF-derived ventricular myocardium (n = 6/6; Fig. 4f–h and Supplementary Fig. 11). In the experimental setup all atrial cardiomyocytes are tbx5a lineage-derived and thus would become mCherry+ if they contributed to the ventricle (Supplementary Fig. 5 and Supplementary Movie 5, n = 9/9). Thus, our results reveal that ventricular tbx5a− SHF-derived cells compensated for the loss of tbx5a+ ventricular cardiomyocytes. To confirm ablation of tbx5a-derived mCherry-NTR expressing cells, we performed terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick end labeling (TUNEL) staining to detect apoptosis (Fig. 5a–g; n = 8 larvae + Mtz group and n = 8 –Mtz group) and detected a significant increase of TUNEL+ mCherry+ trabecular and primordial cardiomyocytes in the Mtz-treated group. In agreement, tagBFP+ ventricular cardiomyocytes incorporated significantly more 5-bBromo-2´-deoxyuridine (BrdU) upon Mtz treatment, indicating proliferation of this cell population (Fig. 5h–m).
Ablation of tbx5a-derived ventricular cardiomyocytes led to a transient impairment of cardiac function. At 7 dpf, right after the Mtz treatment, the ventricles revealed an irregular shape and displayed diminished pumping efficiency (Supplementary Fig. 12a–e and Supplementary Movie 6). However, mortality was not significantly increased (Supplementary Fig. 12f). Indeed, in the adults, the regenerated hearts revealed normal ventricular pumping efficiency (Supplementary Fig. 12g). Taken together, our results demonstrate that the loss of FHF-derived cardiomyocytes is compensated by an expansion of SHF-derived cardiomyocytes.
Cardiomyocyte plasticity during adult heart regeneration
We next explored whether this observed cardiomyocyte plasticity remains in the adult. Upon cryoinjury, cardiomyocytes at the site of injury proliferate and rebuild the lost cortical and trabecular myocardium1,2. Using our transgenic tools, which genetically discriminate between cortical and trabecular cardiomyocytes, we investigated the plasticity of trabecular cardiomyocyte cell fate during regeneration. First, we analysed the expression of tbx5a:GFP during heart regeneration using cryoinjury (Supplementary Fig. 13a). tbx5a:GFP was highly expressed in uninjured trabeculae at all stages analysed. At 1 days postinjury (dpi), no GFP expression could be found in the cortical layer (Supplementary Fig. 13b–f; n = 4/4). In contrast, at 3 dpi (Supplementary Fig. 13g–k; n = 4/5), 7 dpi (Supplementary Fig. 13l–p; n = 3/3), and 21 dpi (Supplementary Fig. 13q–u; n = 4/4), few tbx5a:GFP+ cardiomyocytes could be observed in the cortical layer close to the injured area. Nonetheless, at 130 dpi, the regenerated cortical myocardium was tbx5a:GFP− (Supplementary Fig. 13v–z; n = 4/4). This transient expression of tbx5a in cortical cardiomyocytes can have two explanations: (a) tbx5a is re-expressed transiently in the cortical layer during regeneration, or (b) trabecular cardiomyocytes are contributing to the new cortical layer.
To evaluate these two possibilities, tbx5a-derived cells were genetically traced using tbx5a:mCherry-p2A-CreERT2;ubb:loxP-STOP-loxP-GFP double-transgenic fish (Fig. 6a). Upon recombination, GFP expression was restricted to the trabeculae in uninjured hearts (Fig. 6b–g; n = 7/7) and we only rarely detected GFP+ cells in the cortical myocardium (two cells in one out of six completely sectioned hearts, Supplementary Fig. 14a–f). By contrast, we observed GFP+/mCherry− cells in the regenerated cortical layer at 21 dpi (Fig. 6h–m; n = 6/7) and 90 dpi (Fig. 6n, o–s; n = 6/6), indicating that these cells derived from tbx5a+ cells had switched off tbx5a expression. In the remote area, GFP+ cells remained restricted to the trabecular layer even upon cryoinjury (Fig. 6t–x; n = 5/6). Based on the percentage of trabecular cardiomyocytes that are GFP+, the recombination efficiency was estimated to be 10 ± 6%. In the newly formed cortical layer, 7 ± 4% of cardiomyocytes are GFP+ (n = 10). Therefore, trabeculae might contribute to a higher extent to the regenerating cortical layer than estimated by GFP signal detection.
To confirm that these cells came from tbx5a+ trabeculae and were not produced by leaky recombination in response to injury, we repeated the experiment in the absence of 4-OHT administration; we found no GFP+-recombined cells within the regenerated area (Supplementary Fig. 14g–q; n = 3/3). We further excluded that the result is caused by 4-OHT remaining in the body at the moment of injury through treating zebrafish with 4-OHT 10 and 11 days before the injury (Supplementary Fig. 14r–w; n = 5/5). Taken together, our results reveal that trabeculae contribute to the regeneration of cortical myocardium. This process occurs concomitantly to the downregulation of tbx5a expression, suggesting that trabecular cardiomyocytes change their specification and become cortical cardiomyocytes.
The list of genes to discriminate cortical from trabecular myocardium in the zebrafish is short: besides the herein reported tbx5a expression pattern and nppa29, no other markers have been described to differentiate cortical from trabecular myocardium in the zebrafish. To interrogate whether tbx5a-derived trabecular cardiomyocytes not only relocate into the cortical region and switch off tbx5a but also adopt the expression of cortical marker genes, we performed RNA sequencing (RNA-Seq) comparing tbx5a-positive and -negative cardiomyocytes isolated from adult ventricles (Fig. 7a, b) . tbx5a was the top gene differentially expressed between the two populations (Fig. 7c and Supplementary Data 1), further supporting that the transgenic tbx5a reporter lines reproduce the endogenous pattern. A number of genes related to actin cytoskeleton, extracellular matrix, and caveolae were expressed specifically in tbx5a− cardiomyocytes (Fig. 7c, d): two of these markers, xirp2a30 and lama5, were validated by immunofluorescence for their protein product (Figs. 8 and 9). In uninjured hearts, Xirp2a was detected in the cortical myocardium (Fig. 8a–f, n = 3/3). Strikingly, the tbx5a-derived GFP+ cells that contributed to the cortical layer and switched off tbx5a:mCherry also expressed Xirp2a (Fig. 8g–r, n = 6/6). Laminin was detected in the cortical layer (Fig. 9a–f, n = 3/3) and, upon injury, cortically located tbx5a-derived GFP+ were in a Laminin+ environment; Fig. 9g–r, n = 6/6). This result was further supported using a RNAScope protocol to detect lama5 mRNA in situ (Supplementary Fig. 15; a-h, n = 4/4; i-p, n = 11/11). A third gene used to determine whether tbx5a-derived cardiomyocytes express cortical markers when found in the cortical myocardium was hey2, a well-established marker of the compact layer in the embryonic mouse heart31 (Supplementary Fig. 16). hey2 mRNA in situ detection by RNAScope revealed expression in cardiomyocytes from the cortical myocardium of the adult zebrafish (Supplementary Fig. 16 a-h; n = 3/4). tbx5a-derived trabecular cardiomyocytes that were within the cortical region at 90 dpi co-localized with hey2 staining (Supplementary Fig. 16 i-m; n = 5/6). Of note, tbx5a-derived cells within the trabecular myocardium did not reveal similar hey2 expression levels (Supplementary Fig. 16 n-p; n = 5/6). On the contrary, the expression of the trabecular marker nppa was not retained in tbx5a-derived cells within the cortical myocardium (Supplementary Fig. 17, n = 7/7), altogether indicating that trabecular tbx5a+ cardiomyocytes undergo a true phenotypic switch to become cortical layer cardiomyocytes. Although the cortical myocardium had previously been reported to regenerate from cardiomyocytes within the same layer5, our results reveal that trabecular cardiomyocytes can also contribute to cortical layer repair in response to injury.
In the developing hearts of birds and mammals, a border between Tbx5-positive and -negative cells determines the region of ventricular septation32. Our results here establish that the embryonic ventricle in zebrafish is concomitantly also split into tbx5a+ and tbx5a− domains. A similar boundary between drl+ and drl− cells has been described to separate the embryonic ventricle into domains to control distinct physiological properties11, suggesting that similar to mammals, adult teleost cardiac ventricles maintain FHF and SHF lineage territories (Fig. 10a). Although the zebrafish ventricle is not septated, the presence of a FHF–SHF-like boundary might represent a state that has been further progressed in evolution to allow morphogenetic events leading to septation.
Our results indicate that cardiomyocyte plasticity allows the ventricle to re-form exclusively from SHF-derived cardiomyocytes (Fig. 10b). Of note, in mammals, Tbx5 expression labels the derivatives of the FHF in the ventricle and also the boundary with the SHF19,20; thus, we cannot exclude that the contribution of the SHF is slightly bigger than described in our study. Nonetheless, our results show that SHF cardiomyocytes can compensate the loss of the whole FHF-derived ventricle.
tbx5a lineage tracing allowed (i) to confirm that the cortical layer forms during development from the trabecular myocardium5 and (ii) to identify that this process involves not only a change in location of cardiomyocytes from the trabecular to the cortical regions but also a change in gene expression (Fig. 10a).
In contrast to development, cardiomyocyte plasticity seems to be reduced in the regenerating adult heart:19 conversion of atrial cardiomyocytes to ventricular cardiomyocytes has not been conclusively reported7 and Gupta et al.5 described that the newly regenerated cortical layer derives from pre-exising cortical layer cardiomyocytes. Indeed, the general rule during regeneration is that every cell contributes to the same cell type it was before injury, as illustrated by the cell types comprising the axolotl limb33. In contrast, our results show that a breach of this behavior is possible, with trabecular cardiomyocytes re-specialising into cortical layer cardiomyocytes during regeneration of the adult zebrafish heart (Fig. 10c). This re-specialisation reuses a developmental process in the setting of regeneration to rebuild the injured heart. It is interesting to note that zebrafish hearts are highly trabeculated in comparison with adult mammals. In murine cardiogenesis, the trabecular myocardium is proliferating at a much lower rate than the compact myocardium34. Thus, the switch from a trabecular phenotype to cortical phenotype might additionally allow the cardiomyocytes to re-enter a more active rate of cycling, allowing them to drive the regeneration after cryoinjury in the adult context. We propose that cardiomyocyte plasticity is thus likely a key feature necessary to react efficiently with a regenerative response to injury.
Animal handling and generation of transgenic lines
Ethical approval was obtained from the Community of Madrid “Dirección General de Medio Ambiente” in Spain and the “Amt für Landwirtschaft und Natur” from the Canton of Bern, Switzerland. Animals were housed and experiments performed in accordance with Spanish and Swiss bioethical regulations for the use of laboratory animals. Fish were maintained at a water temperature of 28 °C.
The construct to generate Tg(tbx5a:tdTomato) transgenic zebrafish lines was made by recombining the tdTomato cassette (Supplementary Data 2) into the BAC CH73-99A14. The construct for Tg(tbx5a:mCherry-p2A-CreERT2)cn4 was generated by recombining the iTol2Amp cassette35 (Supplementary Table 1, primers 1,2) and mCherry-p2A-CreERT2 (Supplementary Data 3 and Supplementary Table 1, primers 3,4) into the same BAC. The construct to generate Tg(tbx5a:CreERT2)cn3 was made by recombining iTol2Amp-γ-crystallin:RFP (Supplementary Data 4 and Supplementary Table 2, primers 2,5) and CreERT2 (Supplementary Table 1; primers 4,6) cassettes into the same BAC. Tg(vmhcl:loxP-myctagBFP-STOP-loxP-NTR-mCherry)cn5 was generated using a construct obtained from recombining iTol2Amp35 (Supplementary Table 1, primers 1,2) and loxP-myctagBFP-STOP-loxP-mCherry-NTR (Supplementary Data 5 and Supplementary Table 2, primers 7,8) cassettes into the BAC CH73-204E19. Plasmid templates for recombineering were cloned using Gibson Assembly (NEB). Recombineering was performed combining the pRedET (GeneBridges, Germany) system and EL250 bacteria36. Tg(-3.5ubb:loxP-lacZ-loxP-eGFP)cn226 was outcrossed for six generations to isolate the best insertion. BAC DNA was injected at 25 ng μl−1 into one-cell stage zebrafish embryos along with 1 nl of 50 ng μl−1 synthetic Tol2 mRNA in Danieau buffer. Transient ltbp3:TagRFP-2A-Cre embryos in the stable tbx5a:GFP background were generated by injecting a Tol2 plasmid containing the vector ltbp3:TagRFP-p2A-Cre12 into one-cell stage Tg(tbx5a:GFP) embryos. Around 150 embryos survived the microinjection and were screened for mCherry expression. The transgenic line drl:mCherryzh705 (in full Tg(-6.3drl:mCherry)zh705) based on transgene vector pCM330 was generated using Multisite Gateway assembly of pCM293 (pENTR5’ backbone containing 6.35 kb of the zebrafish drl locus (ZDB-GENE-991213-3) amplified with primers 5′-GTCAGCACCAGATGCCTGTGC-3′ (forward) and 5′-CCAAGTGTGAATTGGGATCG-3′ (reverse) as described37), Tol2kit38#386 (pME-mCherry), #302 (p3E_SV40polyA), and #394 (pDestTol2A2) (in total pDestTol2pA2_drl:mCherry, referred to as drl:mCherry); plasmid DNA was injected at 25 ng μl−1 into one-cell stage zebrafish embryos that were then raised and screened for germline transmission of the transgenic reporter with subsequent outcrossing to isolate a single transgene insertion39. The drl:mCherry transgenics used in the study are at least seventh-generation transgenics. The line Tg(-26.5Hsa.WT1-gata2:EGFP)cn140 contains a reporter construct flanked by flippase recognition target sites, in which cardiac actin drives the expression of RFP. This cassette was removed by injection of flippase mRNA into the one-cell stage. This line was called Tg(−26.5Hsa.WT1-gata2:EGFP)cn12 and was replacing Tg(−26.5Hsa.WT1-gata2:EGFP)cn1.
In adults, 10 µM 4-OHT (Sigma, H7904) was administered at the indicated times. Treatments were performed overnight. Before administration, the 10 mM stock (dissolved in ethanol) was heated 10 min at 65 °C39. For genetic labeling in tbx5a:mCherry-p2A-CreERT2;3.5ubb:loxP-lacZ-loxP-eGFP embryos, 4-OHT was administered at 10 µM from 24 to 48 hpf and at 5 µM from 48 to 84 hpf. Cryoinjury was performed as previously described using a copper filament cooled in liquid nitrogen and placed on the ventricular surface of the heart until thawing41. The pericardial cavity had been previously opened to expose the heart, in anesthetized animals. For genetic ablation experiments and their controls, 4-OHT was administered at 5 µM from 24 to 48 hpf and then Mtz (Sigma, M3761) was added at 10 mM from 96 to 168 hpf. Other lines used were TgBAC(tbx5a:GFP)in2Tg;24 Tg(myl7:nDsRed)f242Tg(myl7:membranemCherry)43, Tg(3.5ubb:loxP-mCherry-loxP-eGFP)44, and Et(−26.5Hsa.WT1-gata2:EGFP)cn1 (epi:GFP)40.
For all the experiments involving Cre recombination or cell ablation, hemizygous fish were used. For experiments using only the Tg(tbx5a:GFP) line, homozygous and hemizygous fish were used interchangeably.
BrdU was added to E3 water at 5 mg ml−1 with 0.5% dimethyl sulfoxide from 4 to 7 dpf.
Samples for Fig. 2a Fig. 3a, and Supplementary Figures 1c–g, 3, 4, 13 and 17 were fixed in 4% pParaformaldehyde (PFA) in phosphate-buffered saline (PBS) overnight at 4 °C. Samples were then washed in 0.1% Tween20 (Merck) in PBS, dehydrated through an ethanol series, and embedded in paraffin wax. Samples were sectioned at 7 μm with a microtome (Leica), sections mounted on Superfrost slides (Fisher Scientific), and dried overnight at 37 °C.
The rest of sections were obtained by fixing in 4% PFA washing in PBS + 0.1% Tween20 (PBT), incubated in 15% saccharose overnight 4 °C. Then, samples were embedded in 30% gelatin 15% saccharose and snap frozen at − 80 °C in isopentane. Tissue was cut at 8 μm on a cryostat (Leica).
In situ mRNA hybridization
In situ mRNA hybridisation on paraffin sections and on whole-mount larvae were performed as described45,46 using tbx5a (complementary DNA kindly provided by C. Neumann), GFP (cDNA kindly provided by J.L. Gómez-Skarmeta), and nppa47 riboprobes.
Paraffin sections were deparaffinized, postfixed 20 min with PFA 4%, washed with PBS, treated with proteinase K 10 µm ml−1 for 10 min at 37 °C, washed with PBS, postfixed with PFA 4% for 5 min, washed with PBS, treated with HCl 0.07 N for 15 min, washed with PBS, treated with 0.25% acetic anhydride in triethanolamine 0.1 M pH 8 for 10 min, washed with PBS, washed with RNase-free water, and then hybridised with the probe in pre-hybridisation buffer over night at 65 °C. The following day, sections were washed twice with post-hybridisation buffer 1 (50% formamide, 5 × SSC, 1% SDS) for 30 min at 65 °C and twice more with post-hybridisation buffer 2 (50% formamide, 2 × saline-sodium citrate SSC, 1% SDS). Then, sections were washed with maleic acid buffer with 0.1% Tween 20 (MABT) buffer at room temperature and incubated at least 2 h in blocking solution at room temperature. They were next incubated overnight with anti-dig-alkaline phosphatase (AP) antibody (1 : 2,000) in blocking solution. The third day, they were washed with MABT for several hours, followed by washes in AP buffer. Sections were developed in BM-Purple (Roche) until signal was detected.
For whole-mount in situ hybridisations, embryos were fixed in 4% PFA overnight, dehydrated in methanol series, and stored at − 20 °C until its use. On day 1, embryos were rehydrated, washed in PBT, digested with 10 µg ml−1 for 15 min, rinsed in PBT, and fixed in 4% PFA for 10 min. After washing again in PBT, they were pre-hybridised at 67 °C for at least 1 h. The antisense riboprobe was added at 0.5 µg ml−1. After overnight hybridisation, two washes with 50% formamide/2 × SSCT, one wash with 2 × SSCT, and an additional two washes with 0.2 × SSCT were performed, all at 67 °C. Then, embryos were transferred to room temperature and washed in MABT. Antibody incubation, washing, and color development condition times were as for in situ on sections. RNAScope (Advanced Cell Diagnostics, Hayward, CA) was performed following the manufacturer’s instructions for formalin-fixed paraffin-embedded samples with standard tissue pretreatment and 2.5 HD RED detection kit.
Immunofluorescence and TUNEL in whole-mount embryos
Embryos were fixed in 4 % PFA overnight, washed in 0.1% Tween20 in PBS, and permeabilised with 0.5% Triton X-100 (Sigma) in PBS for 20 min. Several washing steps were followed by 2 h of blocking with 5% goat serum, 5% bovine serum albumin (BSA), and 20 mM MgCl2 in PBS, followed by incubation with antibodies overnight. Apoptosis was detected by TUNEL staining using the in situ cell death detection kit from Roche (Mannheim, Germany), incubating fish embryos in enzyme solution for 1 h48.
Immunofluorescence on sections
Paraffin sections were deparaffinized, rehydrated, and washed in distilled water. Epitopes were retrieved by heating in 10 mM citrate buffer (pH 6.0) for 15 min in a microwave at full power. Gelatine sections were incubated instead 30 min in 0.1% Tween20 in PBS at 37 °C to dissolve the gelatin. Nonspecific binding sites were saturated by incubation for at least 1 h in blocking solution (5% BSA, 5% goat serum, and 20 mM MgCl2 in PBS). Endogenous biotin was blocked with the avidin–biotin blocking kit (Vector, Burlingame, CA, USA).
Primary antibodies used were anti-Myosin Heavy Chain (MF20, DSHB, 1 : 20 and F59, DSHB, 1 : 20), anti-GFP (AVES, GFP-1010, 1 : 500; 632592, Clontech, Mountain View, CA, USA, 1 : 100), anti-RFP (ab34771, AbCam, 1 : 200), anti-Xirp2a30, a kind gift from C. Otten and S. Seyfried (1 : 500), anti-Laminin (L9393, Sigma, 1 : 200), anti-BrdU (BD Biosciences, B44, 1 : 100), anti-mKate49 to detect tagBFP (1 : 500). Biotin- or Alexa (488, 568, 633)-conjugated secondary antibodies, and streptavidin-Cy3 (Jackson Immuno Research Laboratories) were used at 1 : 300. Nuclei were stained with 4',6-Diamidino-2-phenylindole (DAPI) and slides were mounted in Fluorsave (Calbiochem).
Imaging and Image analysis
Embryos were imaged with a Zeiss 780 confocal microscope using a × 20 objective with a dipping lens. Z-stacks were taken every 1 μm. Three-dimensional images were reconstructed with ImageJ software. A Leica TCS SP-5 or a Nikon A1R confocal microscope was used for imaging of histological sections. The percentage of tagBFP cells was quantified using ImageJ considering the area of tagBFP and comparing it with the area of myosin heavy chain (MHC) staining.
The percentage of tbx5a-derived cells was quantified applying a median filter of radius 1 in ImageJ. The GFP+ and MHC+ areas were measured. The same set of images was used to quantify the percentage of GFP+ cardiomyocytes in trabeculae and in the regenerated compact layer, applying the same threshold for both regions.
In vivo imaging and image processing
Double transgenic Tg(tbx5a:tdTomato);Et(-26.5Hsa.WT1-gata2:EGFP) lines were grown until 60 hpf in E3 culture medium with 0.0033% 1-Phenyl-2thiourea. Embryos were anesthetized with 0.08 mg ml−1 Tricaine and embedded in 1 % low melting agarose (Bio-Rad Low Melt Agarose). Confocal imaging of the embryonic heart was performed with a Zeiss LSM880, using a × 20/0.8 air-objective lens. The green (GFP) and red (tdTomato) channels were acquired simultaneously with maximum speed in bidirectional mode. Z-stacks were acquired over 8 h with 10 min time interval. The range of detection for each channel was adapted to avoid any crosstalk between the channels. A median filter was applied to a representative frame to show co-expression of the epicardial marker and tbx5a.
Ultrasound and assessment of cardiac function in larvae
Measurements and analysis were performed as described47. A mixture of 60 mM of tricaine and 3 mM of isofluorane were added to the tank water in order to anesthetize the animals. A Petri dish was filled with this solution and the fish was placed ventral side up in a foam holder. Once the animal was anesthetised, the images were obtained with a VEVO 2100 system (VisualSonics) coupled to a 50 MHz ultrasound transducer. The probe was lowered until an ultrasound conductive film was formed with the water, so that the skin of the animal was not touched at any time. This way the animal position was rotated till we obtained a long axis view of the heart with a complete visualisation of the ventricular apex. In that moment we recorded cine two-dimensional sequences, with a frame rate of 200 images per second, which were analysed later, in a second step, to minimize anesthesia times.
Imaging of cardiac function in larvae was performed using a Leica AM TIRF MC microscope in epifluorescence mode, using an Andor DU 885K-CS0-#VP (1,004 × 1,002) camera and HCX PL APO 20 × 0,7 dry (11,506,166) objective. The maximum (diastolic) and minimum (systolic) ventricular areas were measured in order to determine ventricular function using Image J.
Heart dissociation followed by sorter and RNA-Seq library production
Zebrafish hearts were dissected and the atrio-ventricular canal was carefully removed in order to obtain a pool of exclusively ventricular cells. The ventricles were dissociated according to previous protocols50 with minor modifications. The enzyme concentration was doubled and time of digestion increased to 1 h and 40 min with gentle agitation while pipetting with a cut 1,000 µl tip every 20–30 min. Then, one volume of PBS + 10% fetal bovine serum (FBS) was added and the mixture was centrifuged for 8 min at 250 g and re-suspended in PBS + 1% FBS. Specifically, the following enzyme concentrations were used: liberase TH (Sigma, 200 mg l−1), Elastase (Serva, 1 : 250), Pronase E (Serva, 1 : 100 dilution of the 26.3 mg ml−1 stock), DNase (Qiagen, 1 : 20,000) and 2,3-butanedione monoxime (Sigma, 10 mM). All reagents were dissolved in Tyrode’s low calcium (in mM): NaCl 140, KCl 5.4, CaCl2 0.01, MgCl2 1.0, glucose 5.5, and HEPES 5.0; pH was set to 7.4 with NaOH.
Cells were sorted using a SONY Synergy sy3200 sorter and RNA was extracted using the Arcturus Pico Pure RNA isolation kit (Thermofisher) following the manufacturer’s instructions.
Total RNA (0.6 ng) was used to generate barcoded RNA-Seq libraries using the Ovation Single Cell RNA-Seq System (NuGEN) with two rounds of library amplification. The size of the libraries was calculated using the Agilent 2100 Bioanalyzer. Library concentration was determined using the Qubit fluorometer (ThermoFisher Scientific). Libraries were sequenced on a HiSeq2500 (Illumina) platform to generate 60-base single reads. FastQ files for each sample were obtained using CASAVA v1.8 software (Illumina). Four biological replicates consisting of five pooled hearts were used per sample.
Sequencing adaptor contaminations were removed from reads using cutadapt 1.9.1 software51 and the resulting reads were mapped and quantified on the transcriptome (Ensembl gene-build 10, release 82) using RSEM v1.2.2552. Only genes with at least one count per million in at least two samples were considered for statistical analysis. Data were then normalised and differential expression tested using the bioconductor package EdgeR53. We considered as differentially expressed those genes with a Benjamini–Hochberg adjusted p-value ≤ 0.05 and log fold change ≥ 1. A heatmap was made using gplot library and heatmap.2 function.
RNA-Seq data have been deposited in the GEO database under accession code GSE87596. The authors declare that all data supporting the findings of this study are available within the article and its supplementary information files or from the corresponding author upon reasonable request. Raw data corresponding to the Figures are deposited at Mendeley: https://doi.org/10.17632/fkm2tvh2sv.1; https://doi.org/10.17632/4fp5f8t7j3.1 and https://doi.org/10.17632/zgdff55m44.1
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
We are grateful to the Animal facility, Histology, Microscopy, Cellomics, Bioinformatics, and Genomics Units from CNIC, the Microscopy Imaging Center from the University of Bern; X. Langa, L. Flores, M. Villalba, and R. Costa for experimental assistance; S. Seyfried and C.-B. Chien for reagents; and M. Torres, S. Martin-Puig, J. González-Sainz-de-Aja, R.M. Benedito, and A. Jazwinska for discussion. Funding was through FPU12/03007 and BFU2014–56970–P (Plan Estatal de Investigación Científica y Técnica y de Innovación 2013–2016, Programa Estatal de I+D+i Orientada a los Retos de la Sociedad Retos Investigación: Proyectos I+D+i 2016, del Ministerio de Economía competitividad e Industria), and co-funding by Fondo Europeo de Desarrollo Regional (FEDER) (H.S. and N.M.); Swiss National Science Foundation grant 31003A_159721, ANR-SNF collaborative Project 320030E-164245, and the ERC starting grant 337703–zebra–Heart (N.M.). A.E. is enrolled into PhD specialization Cutting Edge Microscopy offered by the Graduate School for Cellular and Biomedical Sciences (GCB) and the Microscopy Imaging Center (MIC). The CNIC is supported by the Ministry of Economy, Industry and Competitiveness (MEIC) and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (MEIC award SEV-2015-0505). Further support was from the Canton of Zürich, project grant from the Swiss Heart Foundation (A.F. and C. Mosimann); the Swiss National Science Foundation (SNSF) professorship (PP00P3_139093) and a Marie Curie Career Integration Grant from the European Commission (CIG PCIG14-GA-2013-631984) (C. Mosimann).
Electronic supplementary material
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.